Atosiban
Alternative Names: Antocile; Antocin; Antocin II; CAP 440; CAP 476; deTVT; dTVT; F 314; ORF 22164; RWJ 22164; TractocileLatest Information Update: 24 Oct 2021
At a glance
- Originator Ferring Pharmaceuticals
- Developer Ferring Pharmaceuticals; University of Turin
- Class Tocolytics
- Mechanism of Action Oxytocin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Preterm labour
- Discontinued Cancer